Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Caligan Partners LP
Form 13F · Q2 2026

Caligan Partners LP

CIK 1727492Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$2.1B
Reported book value
28
Positions
12
Quarters on record
Top 50
Positions

Caligan Partners LP — holdings

Top 25 positions of 28, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1LQDA Liquidia Corporation8.1M+0.0%$647M30.5%
2RVMD Revolution Medicines Inc2.0M+18.7%$367M17.3%
3ABVX Abivax Sa1.6M+6.6%$208M9.8%
4PCVX Vaxcyte Inc2.2M+6.2%$127M6.0%
5EXEL Exelixis Inc1.6M+0.0%$85M4.0%
6TNGX Tango Therapeutics Inc2.5M+3.8%$78M3.7%
7AVTX Avalo Therapeutics Inc3.2M+93.5%$58M2.8%
8XENE Xenon Pharmaceuticals Inc889,944−36.1%$54M2.5%
9ADMA Adma Biologics Inc5.7M+20.4%$48M2.3%
10LBRX Lb Pharmaceuticals Inc1.4M+0.0%$47M2.2%
11IMCR Immunocore Hldgs Plc1.4M—$44M2.1%
12VRDN Viridian Therapeutics Inc2.2M—$40M1.9%
13VOR Vor Biopharma Inc1.9M+0.0%$35M1.7%
14SABS Sab Biotherapeutics Inc8.0M+0.0%$31M1.5%
15IVA Inventiva Sa8.2M+64.1%$31M1.5%
16AURA Aura Biosciences Inc4.3M+1769.9%$31M1.4%
17TYRA Tyra Biosciences Inc806,986−36.8%$26M1.2%
18IRD Opus Genetics Inc6.1M+0.0%$25M1.2%
19ANIK Anika Therapeutics Inc1.4M+0.0%$21M1.0%
20SGMT Sagimet Biosciences Inc2.5M—$19M0.9%
21ARTV Artiva Biotherapeutics Inc1.7M—$17M0.8%
22FTH Faeth Therapeutics Inc629,467+399.6%$16M0.7%
23MBX Mbx Biosciences Inc200,000−76.4%$11M0.5%
24VRCA Verrica Pharmaceuticals Inc923,910+0.0%$6M0.3%
25CLRB Cellectar Biosciences Inc469,998—$1M0.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.